Skip to main content
OpenTrials
Completed

NCT Number: NCT05605067

Genetic Architecture of Avoidant/Restrictive Food Intake Disorder

The goal of this observational study is to rapidly accelerate knowledge about the biology of avoidant and restrictive food intake disorder or ARFID in children ages 7-17 and in adults. The investigators will be evaluating the genetic and environmental origins of ARFID. Participants will be asked to answer questionnaires online and to submit a saliva sample for DNA using a kit that will be mailed to their home.

Completed

Looking for future studies?

Notify Me

Key information

Age range

7 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Meet study criteria for ARFID
  • Be willing to submit a saliva sample
  • Have a US mailing address
  • English-speaking

Exclusion criteria

  • Potential other eating disorders

Treatment and study plan

Primary outcomes

  1. Case definitions

    Time frame: Baseline

    Number of enrolled individuals who meet the case definition

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • National Institute of Mental Health (NIMH)
  • Psychiatric Center Ballerup

Registry information

Acronym: ARFID-GEN

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Nov 4, 2022
Registry last updated
Oct 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.